COMPANY PROFILE

Novast

Explore full profile

Novast is focused on the research, development and manufacture of value-added generic drugs

Nantong, ChinaFounded 2005Biotech & Life Sciences

Valuation $100–250M Last recorded · 2009

Total funding $50–100M Disclosed equity funding

At a glance

Status: Closed
Founded: 2005
Headquarters: Nantong, China
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Founder mafia, market maps, research and news connected to this company by Dealroom

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES DOther financing	Sep 2011	—	—	Undisclosed	—
SERIES COther financing	Jun 2011	—	—	Undisclosed	—

Novast website traffic

Latest recorded traffic for Novast is 5.4K monthly website visits, up 42.1% over the last three months.

Latest monthly visits5.4K 3-month web change+42.1%

Monthly website visitsMay 2017–Apr 2018

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RPRivus PharmaceuticalsOperates as a biopharmaceutical company dedicated to improving cardio-metabolic health	Charlottesville, United States	Operational	33	$167M	$528M
VBVero BiotechAn emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions	Atlanta, United States	Operational
IMImaginepharmaDeveloping therapies using its IMG-1 polypeptide for oral delivery, regenerative medicine, and novel therapeutics	Pittsburgh, United States	Low Activity
CHCabinet HealthA sustainable healthcare company, starting with over-the-counter medicine	New York City, United States	Operational
APApoGlyxDeveloping new therapeutic concepts for metabolic and inflammatory diseases with innovative and proprietary Aquaporin technology	Lund Municipality, Sweden	Operational
GAGalenicumProduction and distribution of pharmaceutical goods in various formats	Esplugues de Llobregat, Spain	Operational
PRPredxBioTissue-Based Decision Intelligence for Oncology	Bellevue, United States	Operational
BIBiofourmisBiotechnology company that augments personalized care and therapies using digital therapeutics	Boston, United States	Operational